Objective syndrome differentiation of sepsis based on theory of yin and yang
-
摘要:
脓毒症作为一类复杂性、异质性的临床综合征，可存在多个病性证素及病位，病情变化复杂，阴阳理论能从多个层面呈现脓毒症的宏观及微观变化。本文基于中医阴阳理论从心肾代偿能力、血流动力学变化、免疫反应3个方面探讨脓毒症的客观辨证，以期建立更全面化、客观化的中医诊疗标准。
Abstract:As a complicated and heterogeneous clinical syndrome,sepsis can have multiple disease syndromes and disease sites,leading to complex changes in the disease condition.The theory of yin and yang can present the macro and micro changes of sepsis from multiple levels.Based on the theory of yin and yang in TCM,this article intended to explore the objective syndrome differentiation of sepsis from three aspects: heart and kidney compensatory ability,hemodynamic changes and immune response,in order to establish a more comprehensive and objective standard of diagnosis and treatment in TCM.
-
-
[1] 曹钰,柴艳芬,邓颖,等.中国脓毒症/脓毒性休克急诊治疗指南(2018)[J].感染、炎症、修复,2019,20(1): 3-22. doi: 10.3969/j.issn.1672-8521.2019.01.001 [2] RUDD K E,JOHNSON S C,AGESA K M, et al.Global,regional,and national Sepsis incidence and mortality,1990-2017: analysis for the Global Burden of Disease Study[J].Lancet,2020,395(10219): 200-211. doi: 10.1016/S0140-6736(19)32989-7
[3] 赵国桢,郭玉红,李博,等.中医药防治脓毒症的研究进展[J].中国中药杂志,2017,42(8): 1423-1429. [4] 徐元雯.脓毒症证候-病机特点及客观化研究概况[J].实用中医内科杂志,2017,31(3): 85-87. [5] ZHANG J.Yin and Yang interplay of IFN-gamma in inflammation and autoimmune disease[J].J Clin Invest,2007,117(4): 871-873. doi: 10.1172/JCI31860
[6] 范荣荣.脓毒症致MODS发病态势中证候要素的阶段性特征研究[D].广州: 广州中医药大学,2013. [7] 肖莹莹,周仙仕,唐光华.脓毒症患者中医证候与预后的关系[J].中医杂志,2016,57(3): 224-227. [8] 李春.脓毒症心力衰竭(脓毒症心衰病)的证素和证候分布规律及中医药治疗的临床探索[D].北京: 中国中医科学院,2014. [9] 李思耐,杨思雯,夏非,等.基于中医证候要素的脓毒症预后因素多元Cox模型分析[J].中国中医急症,2020,29(7): 1135-1139. doi: 10.3969/j.issn.1004-745X.2020.07.004 [10] 唐文婷,黄喜胤,彭庆达,等.血尿素氮水平与脓毒症患者中医证候要素的相关性研究[J].国际中医中药杂志,2021,43(2): 123-127. doi: 10.3760/cma.j.cn115398-20200608-00100 [11] 王俊玲,刘婉嫣.参附注射液对脓毒症阳虚患者肾脏保护作用的临床研究[J].中国医药指南,2013,11(2): 264-265. doi: 10.3969/j.issn.1671-8194.2013.02.214 [12] 李培恒.温阳活血化痰法对脓毒症心功能障碍患者H-FABP及NT-proBNP的临床研究[D].合肥: 安徽中医药大学,2018. [13] 石玉君.脓毒症心肌损伤的证素证型分布规律及其相关因素的临床研究[D].北京: 中国中医科学院,2017. [14] 杨金亮,刘善伟,刘玉霞.新四逆汤对脓毒症心肌顿抑患者无创血流动力学的影响[J].世界中西医结合杂志,2019,14(8): 1160-1162. [15] 麦舒桃,韩云,谢东平,等.脓毒症休克患者早期中医证候要素与PiCCO监测指标的关系研究[J].广州中医药大学学报,2014,31(3): 335-338. [16] 毛凯凤.基于PiCCO监测脓毒症休克中医药干预方案疗效评价研究[D].广州: 广州中医药大学,2019. [17] 赖芳,郑义,曾瑞峰,等.脓毒症中医阴阳证型分布特点与免疫功能障碍的相关性研究[J].中华中医药杂志,2020,35(8): 4159-4164. [18] 赖芳,郑义,曾瑞峰,等.四逆汤对严重脓毒症阴证患者免疫功能的影响[J].中医杂志,2020,61(9): 789-795. [19] 郑义.四逆汤对阴证脓毒症免疫功能影响的临床研究[D].广州: 广州中医药大学,2018. [20] VIJAYAN A L,VANIMAYA,RAVINDRAN S, et al.Procalcitonin: a promising diagnostic marker for Sepsis and antibiotic therapy[J].J Intensive Care,2017,5: 51.
[21] STANDAGE S W,WONG H R.Biomarkers for pediatric Sepsis and septic shock[J].Expert Rev Anti Infect Ther,2011,9(1): 71-79.
[22] 麦舒桃,翁燕娜,杜炯栋,等.严重脓毒症及脓毒症休克阴阳辨证与炎症指标的相关性研究[J].北京中医药大学学报,2014,21(11): 736-739,747. [23] HOTCHKISS R S,MONNERET G,PAYEN D.Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy[J].Nat Rev Immunol,2013,13(12): 862-874.
[24] 高冬娜.脓毒症中医辩证分型、负性共刺激分子表达和参芪扶正疗效的临床研究[D].大连: 大连医科大学,2017. [25] 卢云,焦旭."西学中用""病证结合"治疗危急重症[J].中国中医急症,2016,25(6): 1018-1022. [26] 韩金祥.中医理论与量子理论思维方式的相容性和可转化性探讨[J].山东中医药大学学报,2013,37(4): 267-270.
计量
- 文章访问数: 254
- HTML全文浏览量: 89
- PDF下载量: 5
下载:
苏公网安备 32100302010246号
